Skip to main content

Table 2 CpG sites that correlate with both exon expression and survival outcome

From: Comprehensive analysis of TCGA data reveals correlation between DNA methylation and alternative splicing

CpG

Gene

Cancer

P-value

FDR

cg20351640

CD302

brain

1.70E-08

0.000138852

cg03903831

RP11-307N16.6

brain

3.51E-08

0.000181116

cg27048140

ATP5J2-PTCD1

brain

8.93E-08

0.000289902

cg19857457

RPL17-C18orf32

breast

1.09E-08

0.000337161

cg03903831

SPATA13

brain

1.88E-07

0.000432463

cg05032848

RFFL

brain

2.45E-07

0.000497251

cg20477147

NPEPL1

brain

3.95E-07

0.000600647

cg24859623

CD302

brain

3.95E-07

0.000600647

cg09088496

RP11-307N16.6

brain

3.86E-07

0.000600647

cg04735129

CD302

brain

4.81E-07

0.000657035

cg08347373

CD302

brain

5.69E-07

0.000711062

cg08278937

SERINC4

brain

7.10E-07

0.000783884

cg16992627

TNXB

brain

8.01E-07

0.000830607

cg21870038

RFFL

brain

8.07E-07

0.000830823

cg13586610

TNXB

brain

1.07E-06

0.000969694

cg22158248

ALDH2

brain

1.23E-06

0.001040217

cg13799005

RP11-644F5.10

brain

1.25E-06

0.001049216

cg09088496

SPATA13

brain

1.97E-06

0.00123508

cg06017559

RP11-161M6.2

brain

2.34E-06

0.001332273

cg07204711

CDK3

brain

2.32E-06

0.001332273

  1. *P-value and FDR are for log-rank test of CpG association with survival